Effects of hyodeoxycholic acid and alpha-hyocholic acid, two 6 alpha-hydroxylated bile acids, on cholesterol and bile acid metabolism in the hamster.
The effects of hyodeoxycholic (HDCA) and alpha-hyocholic acids (alpha-HCA), on cholesterol, bile acid and lipoprotein metabolism, were studied in hamsters. The animals were fed a low cholesterol control diet supplemented with 0.1% HDCA or alpha-HCA for 3 weeks. In both treated groups, the LDL-cholesterol concentration was significantly lowered and was associated with a global hypocholesterolemic effect. Moreover, hepatic cholesterol ester storage was reduced and HMGCoA reductase activity was respectively enhanced 13.5-times and 7.7-times in HDCA and alpha-HCA groups compared to controls. In contrast, cholesterol 7 alpha-hydroxylase activity and LDL-receptor activity and mass were not modified. In bile, the cholesterol saturation index was increased 5-fold (HDCA group) and 2-fold (alpha-HCA group) as a consequence of an enlarged proportion of biliary cholesterol. The two 6-hydroxylated bile acids induced an enhanced fecal excretion of neutral sterols (HDCA group: 11.6-times, alpha-HCA group: 3.2-times versus controls) which was consistent with a 59% decrease in intestinal cholesterol absorption in the HDCA group. The major effects due to bile acid treatments were a decrease in LDL-cholesterol concentration, a strong stimulation of hepatic cholesterol biosynthesis and an excessive loss of cholesterol in feces. These perturbations might be the result of the enrichment of bile with hydrophilic bile acids, leading to a limited return of endogenous cholesterol from the intestine to the liver.
Cohen-Solal
C
C
URA INRA Physiologie de la Nutrition, Université Paris-Sud, Orsay, France.
Parquet
M
M
Férézou
J
J
Sérougne
C
C
Lutton
C
C
D000818:Animals; D001646:Bile / Q000378:metabolism; D001647:Bile Acids and Salts / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism*; D002793:Cholic Acids / Q000008:administration & dosage*; D006224:Cricetinae; D003840:Deoxycholic Acid / Q000008:administration & dosage*; D004032:Diet; D007408:Intestinal Absorption; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008647:Mesocricetus; D011973:Receptors, LDL / Q000032:analysis
D001647:Bile Acids and Salts; D002793:Cholic Acids; D008074:Lipoproteins; D011973:Receptors, LDL; D003840:Deoxycholic Acid; C004821:muricholic acid; C010471:hyodeoxycholic acid; D002784:Cholesterol